POLYMERS FOR GENE THERAPY (Machine-translation by Google Translate, not legally binding)
ES2808994A1
System for implantation by sterilization techniques (Machine-translation by Google Translate, not legally binding)
WO2021058708A1
Transgenic non-human models for lipodystrophy and/or peld
ES2797556A1
SUPRAMOLECULAR FLUID
ES2796448A1
BATTERY COMPOUND
WO2021028610A2
Compounds and methods for treating cancer
ES2788975A1
COMPOSITION FOR BIOACTIVE PACKAGING (Machine-translation by Google Translate, not legally binding)
WO2020221849A1
Intracellular delivery of anti-kras antibodies formulated into nanocapsules
WO2020161206A1
In vitro method for the diagnosis of viral infections
WO2020136292A1
Compounds of pharmaceutical interest
ES2755415A1
HYDROGELS THAT INCLUDE A NITROGEN BASED
WO2020094700A1
Stable polymer composites
WO2020058533A1
Obestatin for use in the treatment of peripheral nerve damages or injuries
WO2020043792A1
Method for determining interfacial tension
ES2804076A1
PHARMACEUTICAL COMPOSITION FOR USE IN THE PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF L-DOPA-INDUCED DYSKINESIAS (Machine-translation by Google Translate, not legally binding)
WO2020016474A1
Nanosystems with complexes
WO2020011896A1
Nanostructure lipid system
EP3715757A1
Electrode assembly
EP3715473A1
Prognostic markers, therapeutic target and treatment for acromegaly
WO2019162362A1
Method for detoxification of food, feed and water contaminated with natural toxins
